German scientists have found clinical factors that may identify type 1 diabetes before it even occurs….
Read More »Empagliflozin Improves CV Risk Factors in T2DM
According to the results of four phase III clinical trials, twenty-four weeks of treatment achieved clinically meaningful improvements in cardiovascular risk factors as well as in glycemic control….
Read More »Statins May Work in Children and Adolescents with Type 1 Diabetes
A small randomized trial showed that statins may be an effective and safe way to treat high LDL cholesterol in children and adolescents….
Read More »Peanut Butter at Breakfast Helps Control Hunger and Blood Sugar All Day
Consuming peanut butter or peanuts for breakfast can control blood sugar throughout most of the day, even after eating a high carbohydrate lunch… In addition to this “Second Meal Effect,” peanuts and peanut butter caused a significant reduction in the desire to eat for up to 12 hours and a …
Read More »1,5-Anhydroglucitol Outcomes Research and Link to Complications, Part 4 of 4
In this week’s set of Homerun Slides, we conclude our four-part series on 1,5-Anhydroglucitol, which shows significant and predictive links to several diabetic complications including retinopathy, cardiovascular disease in both men and women, and neonatal birth weight among others….
Read More »ADA/JDRF Type 1 Diabetes Sourcebook, Excerpt #5: Nutrition, Part 1
Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor Marion J. Franz, MS, RD, CDE; Alison B. Evert, MS, RD, CDE; Gail Spiegel, MS, RD, CDE; Carol Brunzell, RD, CDE; Joyce Green Pastors, MS, RD, CDE; Joshua J. Neumiller, PharmD, CDE, CGP, FASCP; Laurie …
Read More »Quantose™
Quantose™ A lab test to find pre-diabetes earlier. The manufacturer Metabolon has discovered a number of significant biochemical markers indicative of risk for type 2 diabetes. These markers are currently being incorporated in the development of the Quantose series of diagnostic products. The first-generation Quantose product is a diagnostic test …
Read More »ADA: 18 Years Later, A1c Matters for DCCT Intensive Control Group
The results continue to show dramatic reductions in complications….
Read More »ADA: Major Advance towards an Artificial Pancreas
"Smart" device that reduces low blood glucose levels overnight undergoing FDA review….
Read More »ADA: Lifestyle Invention Doesn’t Reduce Cardiovascular Events in Type 2 Obese Adults
Lifestyle changes in obese patients with type 2 diabetes can decrease some complications and even medical costs, but….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.